Page last updated: 2024-12-06

stictic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Stictic acid is a lichen secondary metabolite with a complex structure, belonging to the depside family. It has been studied extensively due to its diverse biological activities, including antibacterial, antifungal, antiviral, and cytotoxic properties. The molecule exhibits strong antioxidant activity, which has been linked to its potential therapeutic applications. It has been isolated from various lichen species and synthesized in the laboratory. Notably, its biosynthesis pathway in lichens involves a series of enzymatic reactions, starting from simple precursors like polyketides. The mechanism of action behind its biological effects is complex and involves interactions with various cellular components, including enzymes and DNA. Research into stictic acid continues, focusing on its potential as a lead compound for developing novel drugs and understanding the intricate relationship between lichen metabolites and their ecological roles.'

stictic acid: antioxidant from lichen, Usnea articulata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73677
CHEMBL ID173530
CHEBI ID93839
SCHEMBL ID13495711
MeSH IDM0512587

Synonyms (59)

Synonym
BRD-A29578214-001-02-7
NCI60_041935
SDCCGMLS-0066543.P001
SPECTRUM_000600
SPECTRUM5_000031
dihydroxy-methoxy-dimethyl-dioxo-[?]carbaldehyde
7h-isobenzofuro[4,5-b][1,4]benzodioxepin-11-carboxaldehyde,1,3-dihydro-1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-
549-06-4
NSC87511 ,
stictic acid
nsc-87511
isophthalaldehydic acid,.alpha.2,4,6-tetrahydroxy-2,5-xylyl)oxy]-4-methoxy-6-methyl-, .gamma.-lactone, .epsilon.-lactone
MLS001049107
smr000386939
NCGC00095566-01
KBIO2_006216
KBIO3_002329
KBIOSS_001080
KBIO2_001080
KBIO2_003648
KBIOGR_001931
SPECTRUM2_000307
SPECTRUM3_001185
SPBIO_000274
SPECTRUM4_001446
SPECTRUM300006
BSPBIO_002829
NCGC00095566-03
NCGC00095566-02
1,3-dihydro-1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-7h-isobenzofuro(4,5-b)(1,4)benzodioxepin-11-carboxaldehyde
CHEMBL173530 ,
stictic acid (sta), 1
cid_73677
bdbm50056922
1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-1,3-dihydro-7h-benzo[e]furo[3'',4'':3,4]benzo[b][1,4]dioxepine-11-carbaldehyde
HMS2271H11
CCG-38584
7h-isobenzofuro(4,5-b)(1,4)benzodioxepin-11-carboxaldehyde, 1,3-dihydro-1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-
nzr6ax77lp ,
nsc 87511
unii-nzr6ax77lp
REGID_FOR_CID_73677
SCHEMBL13495711
7h-isobenzofuro[4,5-b][1,4]benzodioxepin-11-carboxaldehyde, 1,3-dihydro-1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-
SKCUFZLDTAYNBZ-UHFFFAOYSA-N
1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-1,3-dihydro-7h-2,6,12-trioxabenzo[5,6]cyclohepta[1,2-e]indene-11-carbaldehyde #
sr-01000758942
SR-01000758942-2
AKOS027326813
CHEBI:93839
Q3604558
13,17-dihydroxy-5-methoxy-7,12-dimethyl-9,15-dioxo-2,10,16-trioxatetracyclo[9.7.0.03,8.014,18]octadeca-1(11),3(8),4,6,12,14(18)-hexaene-4-carbaldehyde
BRD-A29578214-001-08-4
DTXSID20972053
1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-1,3-dihydro-7h-2,6,12-trioxabenzo[5,6]cyclohepta[1,2-e]indene-11-carbaldehyde
STL564823
sticticacid
scopularic acid
1,3-dihydro-1,4-dihydroxy-10-methoxy-5,8-dimethyl-3,7-dioxo-7h-isobenzofuro[4,5-b][1,4]benzodioxepin-11-carboxaldehyde
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (67)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency17.70820.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency23.60910.004023.8416100.0000AID485290; AID489007
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency79.43280.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency22.38720.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency22.47600.125919.1169125.8920AID2549
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
WRNHomo sapiens (human)Potency50.11870.168331.2583100.0000AID651768
phosphopantetheinyl transferaseBacillus subtilisPotency25.11890.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency36.04150.031637.5844354.8130AID504865; AID743255
GLS proteinHomo sapiens (human)Potency2.81840.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency10.32250.000811.382244.6684AID686978
Microtubule-associated protein tauHomo sapiens (human)Potency17.56150.180013.557439.8107AID1460; AID1468
thioredoxin glutathione reductaseSchistosoma mansoniPotency19.95260.100022.9075100.0000AID485364
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency25.11890.707912.194339.8107AID720542
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency28.18380.011212.4002100.0000AID1030
isocitrate dehydrogenase 1, partialHomo sapiens (human)Potency50.11876.309627.099079.4328AID602179
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency79.43280.707936.904389.1251AID504333
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency22.53580.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency50.76170.354828.065989.1251AID504847
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency32.86820.010039.53711,122.0200AID1469; AID1479
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency31.62283.548119.542744.6684AID743266
importin subunit beta-1 isoform 1Homo sapiens (human)Potency54.60005.804836.130665.1308AID540253; AID540263
DNA polymerase betaHomo sapiens (human)Potency7.94330.022421.010289.1251AID485314
flap endonuclease 1Homo sapiens (human)Potency47.81950.133725.412989.1251AID588795; AID720498
snurportin-1Homo sapiens (human)Potency54.60005.804836.130665.1308AID540253; AID540263
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency89.12510.010323.856763.0957AID2662
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency19.95260.425612.059128.1838AID504891
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency9.20005.804816.996225.9290AID540253
DNA polymerase eta isoform 1Homo sapiens (human)Potency18.59010.100028.9256213.3130AID588591; AID720502
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency43.47620.050127.073689.1251AID588590; AID720496
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency31.62280.075215.225339.8107AID485360
gemininHomo sapiens (human)Potency29.09290.004611.374133.4983AID624296
DNA polymerase kappa isoform 1Homo sapiens (human)Potency28.93420.031622.3146100.0000AID588579
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency79.43280.00419.962528.1838AID2675
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Rap guanine nucleotide exchange factor 4Homo sapiens (human)Potency56.23413.981146.7448112.2020AID720708
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency13.49660.07578.474229.0628AID602233; AID686980
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, RNA-directed RNA polymerase NS5Dengue virus 2 16681-PDK53IC50 (µMol)71.17002.370054.1398100.0000AID588689
SUMO-1Homo sapiens (human)IC50 (µMol)37.14500.64707.494715.9000AID624382; AID624383
3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZYersinia pseudotuberculosis YPIIIIC50 (µMol)20.40005.30006.12507.7000AID1801643
RAD51Homo sapiens (human)IC50 (µMol)46.86801.399017.721432.1000AID1435; AID1436
microphthalmia-associated transcription factor isoform 9Homo sapiens (human)IC50 (µMol)2.87150.00481.37104.9290AID1259371; AID1259373; AID1259375
Dual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)IC50 (µMol)24.00000.00100.97984.5000AID1799757
Integrase Human immunodeficiency virus 1IC50 (µMol)4.70000.00051.544310.0000AID93700; AID93702; AID93703; AID93705; AID93707
14 kDa phosphohistidine phosphataseHomo sapiens (human)IC50 (µMol)22.00007.90007.90007.9000AID1870205
M1-family alanyl aminopeptidasePlasmodium falciparum 3D7IC50 (µMol)27.28002.600048.1803128.9800AID1445
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
serine/threonine-protein kinase 33 isoform aHomo sapiens (human)EC50 (µMol)32.03000.769114.609644.8900AID2821
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Caspase 6, apoptosis-related cysteine peptidaseHomo sapiens (human)AC500.81700.063611.235844.9700AID720632
Caspase-7Homo sapiens (human)AC5044.33000.371017.049168.4900AID743295
Caspase-8Homo sapiens (human)AC5070.00000.310012.451547.9700AID743294
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (92)

Processvia Protein(s)Taxonomy
MAPK cascadeDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
osteoblast differentiationDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
positive regulation of protein phosphorylationDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
response to ischemiaDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
apoptotic processDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
signal transductionDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
response to xenobiotic stimulusDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
ovulation cycle processDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
stress-activated protein kinase signaling cascadeDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
positive regulation of prostaglandin secretionDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathwayDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
p38MAPK cascadeDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
signal transduction in response to DNA damageDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
positive regulation of apoptotic processDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
positive regulation of MAPK cascadeDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
stress-activated MAPK cascadeDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
regulation of cell cycleDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
positive regulation of nitric-oxide synthase biosynthetic processDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
cardiac muscle contractionDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
bone developmentDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
cellular response to sorbitolDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
cellular senescenceDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
negative regulation of cold-induced thermogenesisDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
regulation of signal transduction by p53 class mediatorDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
proteolysisCaspase-7Homo sapiens (human)
apoptotic processCaspase-7Homo sapiens (human)
heart developmentCaspase-7Homo sapiens (human)
response to UVCaspase-7Homo sapiens (human)
protein processingCaspase-7Homo sapiens (human)
protein catabolic processCaspase-7Homo sapiens (human)
defense response to bacteriumCaspase-7Homo sapiens (human)
fibroblast apoptotic processCaspase-7Homo sapiens (human)
striated muscle cell differentiationCaspase-7Homo sapiens (human)
neuron apoptotic processCaspase-7Homo sapiens (human)
protein maturationCaspase-7Homo sapiens (human)
lymphocyte apoptotic processCaspase-7Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-7Homo sapiens (human)
cellular response to staurosporineCaspase-7Homo sapiens (human)
execution phase of apoptosisCaspase-7Homo sapiens (human)
positive regulation of plasma membrane repairCaspase-7Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-7Homo sapiens (human)
angiogenesisCaspase-8Homo sapiens (human)
regulation of cytokine productionCaspase-8Homo sapiens (human)
proteolysisCaspase-8Homo sapiens (human)
apoptotic processCaspase-8Homo sapiens (human)
heart developmentCaspase-8Homo sapiens (human)
regulation of tumor necrosis factor-mediated signaling pathwayCaspase-8Homo sapiens (human)
natural killer cell activationCaspase-8Homo sapiens (human)
macrophage differentiationCaspase-8Homo sapiens (human)
positive regulation of cell migrationCaspase-8Homo sapiens (human)
response to cobalt ionCaspase-8Homo sapiens (human)
response to estradiolCaspase-8Homo sapiens (human)
response to lipopolysaccharideCaspase-8Homo sapiens (human)
positive regulation of interleukin-1 beta productionCaspase-8Homo sapiens (human)
response to tumor necrosis factorCaspase-8Homo sapiens (human)
TRAIL-activated apoptotic signaling pathwayCaspase-8Homo sapiens (human)
T cell activationCaspase-8Homo sapiens (human)
B cell activationCaspase-8Homo sapiens (human)
positive regulation of apoptotic processCaspase-8Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionCaspase-8Homo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionCaspase-8Homo sapiens (human)
regulation of innate immune responseCaspase-8Homo sapiens (human)
response to ethanolCaspase-8Homo sapiens (human)
positive regulation of macrophage differentiationCaspase-8Homo sapiens (human)
positive regulation of proteolysisCaspase-8Homo sapiens (human)
proteolysis involved in protein catabolic processCaspase-8Homo sapiens (human)
protein maturationCaspase-8Homo sapiens (human)
negative regulation of necroptotic processCaspase-8Homo sapiens (human)
syncytiotrophoblast cell differentiation involved in labyrinthine layer developmentCaspase-8Homo sapiens (human)
pyroptosisCaspase-8Homo sapiens (human)
cellular response to mechanical stimulusCaspase-8Homo sapiens (human)
cellular response to organic cyclic compoundCaspase-8Homo sapiens (human)
apoptotic signaling pathwayCaspase-8Homo sapiens (human)
extrinsic apoptotic signaling pathwayCaspase-8Homo sapiens (human)
execution phase of apoptosisCaspase-8Homo sapiens (human)
activation of cysteine-type endopeptidase activityCaspase-8Homo sapiens (human)
self proteolysisCaspase-8Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processCaspase-8Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsCaspase-8Homo sapiens (human)
positive regulation of neuron apoptotic processCaspase-8Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 4Homo sapiens (human)
G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 4Homo sapiens (human)
calcium-ion regulated exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of exocytosisRap guanine nucleotide exchange factor 4Homo sapiens (human)
insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
positive regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of synaptic vesicle cycleRap guanine nucleotide exchange factor 4Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 4Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 4Homo sapiens (human)
Rho protein signal transductionRho guanine nucleotide exchange factor 1Homo sapiens (human)
regulation of small GTPase mediated signal transductionRho guanine nucleotide exchange factor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayRho guanine nucleotide exchange factor 1Homo sapiens (human)
protein dephosphorylation14 kDa phosphohistidine phosphataseHomo sapiens (human)
actin cytoskeleton organization14 kDa phosphohistidine phosphataseHomo sapiens (human)
peptidyl-histidine dephosphorylation14 kDa phosphohistidine phosphataseHomo sapiens (human)
negative regulation of T cell receptor signaling pathway14 kDa phosphohistidine phosphataseHomo sapiens (human)
negative regulation of lyase activity14 kDa phosphohistidine phosphataseHomo sapiens (human)
lamellipodium organization14 kDa phosphohistidine phosphataseHomo sapiens (human)
positive regulation of cell motility14 kDa phosphohistidine phosphataseHomo sapiens (human)
negative regulation of ATP citrate synthase activity14 kDa phosphohistidine phosphataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (32)

Processvia Protein(s)Taxonomy
protein serine/threonine kinase activityDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
MAP kinase kinase activityDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
protein tyrosine kinase activityDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
protein bindingDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
ATP bindingDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
protein kinase bindingDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
protein serine kinase activityDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
RNA bindingCaspase-7Homo sapiens (human)
aspartic-type endopeptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-7Homo sapiens (human)
protein bindingCaspase-7Homo sapiens (human)
peptidase activityCaspase-7Homo sapiens (human)
cysteine-type peptidase activityCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activity involved in execution phase of apoptosisCaspase-7Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-8Homo sapiens (human)
death receptor bindingCaspase-8Homo sapiens (human)
tumor necrosis factor receptor bindingCaspase-8Homo sapiens (human)
protein bindingCaspase-8Homo sapiens (human)
peptidase activityCaspase-8Homo sapiens (human)
cysteine-type peptidase activityCaspase-8Homo sapiens (human)
ubiquitin protein ligase bindingCaspase-8Homo sapiens (human)
death effector domain bindingCaspase-8Homo sapiens (human)
identical protein bindingCaspase-8Homo sapiens (human)
protein-containing complex bindingCaspase-8Homo sapiens (human)
scaffold protein bindingCaspase-8Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic processCaspase-8Homo sapiens (human)
cysteine-type endopeptidase activity involved in apoptotic signaling pathwayCaspase-8Homo sapiens (human)
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
protein-macromolecule adaptor activityRap guanine nucleotide exchange factor 4Homo sapiens (human)
small GTPase bindingRap guanine nucleotide exchange factor 4Homo sapiens (human)
RNA bindingRho guanine nucleotide exchange factor 1Homo sapiens (human)
guanyl-nucleotide exchange factor activityRho guanine nucleotide exchange factor 1Homo sapiens (human)
GTPase activator activityRho guanine nucleotide exchange factor 1Homo sapiens (human)
protein bindingRho guanine nucleotide exchange factor 1Homo sapiens (human)
G protein-coupled receptor bindingRho guanine nucleotide exchange factor 1Homo sapiens (human)
protein binding14 kDa phosphohistidine phosphataseHomo sapiens (human)
calcium channel inhibitor activity14 kDa phosphohistidine phosphataseHomo sapiens (human)
transmembrane transporter binding14 kDa phosphohistidine phosphataseHomo sapiens (human)
actin filament binding14 kDa phosphohistidine phosphataseHomo sapiens (human)
protein histidine phosphatase activity14 kDa phosphohistidine phosphataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (20)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
cytoplasmDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
cytosolDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
nucleoplasmDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
cytosolDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
cytoskeletonDual specificity mitogen-activated protein kinase kinase 6Homo sapiens (human)
extracellular spaceCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
cytoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
nucleusCaspase-7Homo sapiens (human)
nucleoplasmCaspase-7Homo sapiens (human)
cytosolCaspase-7Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
cytoplasmCaspase-8Homo sapiens (human)
nucleoplasmCaspase-8Homo sapiens (human)
mitochondrionCaspase-8Homo sapiens (human)
mitochondrial outer membraneCaspase-8Homo sapiens (human)
cytosolCaspase-8Homo sapiens (human)
cytoskeletonCaspase-8Homo sapiens (human)
lamellipodiumCaspase-8Homo sapiens (human)
cell bodyCaspase-8Homo sapiens (human)
death-inducing signaling complexCaspase-8Homo sapiens (human)
CD95 death-inducing signaling complexCaspase-8Homo sapiens (human)
protein-containing complexCaspase-8Homo sapiens (human)
ripoptosomeCaspase-8Homo sapiens (human)
cytosolRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseRap guanine nucleotide exchange factor 4Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 4Homo sapiens (human)
cytosolRho guanine nucleotide exchange factor 1Homo sapiens (human)
plasma membraneRho guanine nucleotide exchange factor 1Homo sapiens (human)
cytoplasmRho guanine nucleotide exchange factor 1Homo sapiens (human)
nucleoplasm14 kDa phosphohistidine phosphataseHomo sapiens (human)
cytosol14 kDa phosphohistidine phosphataseHomo sapiens (human)
plasma membrane14 kDa phosphohistidine phosphataseHomo sapiens (human)
nuclear body14 kDa phosphohistidine phosphataseHomo sapiens (human)
leading edge of lamellipodium14 kDa phosphohistidine phosphataseHomo sapiens (human)
extracellular exosome14 kDa phosphohistidine phosphataseHomo sapiens (human)
cytosol14 kDa phosphohistidine phosphataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (63)

Assay IDTitleYearJournalArticle
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID93705Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 11997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
AID1127170Chemical stability of the compound in methanol measured at 72 hrs by LC-MS analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1316797Inhibition of wild type His-tagged translin/trax E126A mutant (unknown origin) coexpressed in Escherichia coli BL21 cells using RNase Alert as substrate at 30 uM incubated for 10 mins prior to substrate addition monitored over 60 mins by fluorescence assa2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
A druggable target for rescuing microRNA defects.
AID1718562Inhibition of angiogenesis in HEPC-CB1 cells assessed as decrease in pseudovessels at 20 uM after 13 hrs by fluorescence inverted microscopic analysis2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID93703Inhibitory concentration of compound against disintegration (reversal of strand transfer)of HIV-1 integrase1997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
AID91562Percentage inhibition against strand transfer of HIV-1 integrase at 100 ug/mL1997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
AID93700Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 11997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
AID1718547Inhibition of bovine lung sGC assessed as reduction in GMP level incubated for 2 hrs in presence of NPS/BAY-412272 by ELISA2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1718553Selectivity ratio of IC50 for inhibition of bovine lung sGC assessed as reduction in GMP level in presence of NPS/BAY-412272 to IC50 for inhibition of bovine lung sGC assessed as reduction in GMP level in presence of NPS2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID91561Percentage inhibition of compound against 3'-processing of HIV-1 integrase at 100 ug/mL1997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
AID1127168Chemical stability of the compound in methanol measured at 24 hrs by LC-MS analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1718560Inhibition of angiogenesis in HEPC-CB1 cells assessed as decrease in total length of pseudovessels at 20 uM after 13 hrs by fluorescence inverted microscopic analysis2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1718544Inhibition of human sGC expressed in HUVEC cells assessed as reduction in GMP level incubated for 24 hrs by ELISA2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1127167Chemical stability of the compound in methanol measured immediately post compound addition by LC-MS analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1127160Cytotoxicity against human HeLa cells after 48 hrs by WST-1 assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1718556Inhibition of bovine lung sGC assessed as reduction in GMP level incubated for 2 to 12 hrs in presence of NPS by ELISA2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1870207Time dependent inhibition of PHPT1 (unknown origin) at 20 uM using DiFMUP as fluorogenic substrate preincubated for 15 to 120 mins followed by substrate addition and measured for 30 mins by fluorogenic assay2022ACS medicinal chemistry letters, Jul-14, Volume: 13, Issue:7
Inhibitor Screen Identifies Covalent Inhibitors of the Protein Histidine Phosphatase PHPT1.
AID1718568Cytotoxicity against rat hepatocytes assessed as induction intracellular LDH release incubated for 8 to 24 hrs2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1127169Chemical stability of the compound in methanol measured at 48 hrs by LC-MS analysis2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1355864Inhibition of p115 DHPH22 domain (395 to 766 residues) (unknown origin) interaction with GDP-loaded His-tagged RhoA F25N mutant (1 to 180 residues) assessed as reduction in BODIPY-GTP-GDP exchange at 200 uM pretreated for 30 mins followed by RhoA addition2018Journal of natural products, 07-27, Volume: 81, Issue:7
Natural Inhibitors of the RhoA-p115 Complex from the Bark of Meiogyne baillonii.
AID1127157Cytotoxicity against human HL60 cells after 24 hrs by WST-1 assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1870205Inhibition of PHPT1 (unknown origin) using DiFMUP as fluorogenic substrate incubated for 30 mins followed by substrate addition and measured every 60 seconds for 30 mins by fluorogenic assay2022ACS medicinal chemistry letters, Jul-14, Volume: 13, Issue:7
Inhibitor Screen Identifies Covalent Inhibitors of the Protein Histidine Phosphatase PHPT1.
AID1718569Inhibition of Yersinia pestis FabZ2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1718554Inhibition of full length human sGC expressed in HUVEC cells assessed as increase in oxidation of heme at 20 uM after 2 hrs by spectroscopic analysis2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID93702Inhibitory concentration of compound against 3'-processing of HIV-1 integrase in experiment 21997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
AID1718543Inhibition of bovine lung sGC assessed as reduction in GMP level incubated for 2 hrs in presence of NPS by ELISA2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1718540Inhibition of human sGC expressed in HUVEC cells assessed as reduction in GMP level incubated for 24 hrs in presence of NPS by ELISA2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1127162Cytotoxicity against African green monkey Vero cells after 48 hrs by Alamar Blue assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1718548Inhibition of bovine lung sGC assessed as reduction in GMP level incubated for 2 hrs in presence of BAY-412272 by ELISA2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1127161Cytotoxicity against African green monkey Vero cells after 24 hrs by Alamar Blue assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1718561Inhibition of angiogenesis in HEPC-CB1 cells assessed as decrease in number of closed structures at 20 uM after 13 hrs by fluorescence inverted microscopic analysis2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1355866Inhibition of Net1 (149 to 501 residues) (unknown origin) interaction with GDP-loaded His-tagged RhoA F25N mutant (1 to 180 residues) assessed as reduction in BODIPY-GTP-GDP exchange at 200 uM pretreated for 30 mins followed by RhoA addition by fluorescen2018Journal of natural products, 07-27, Volume: 81, Issue:7
Natural Inhibitors of the RhoA-p115 Complex from the Bark of Meiogyne baillonii.
AID1718570Inhibition of Francisella tularensis FabZ2020Journal of natural products, 12-24, Volume: 83, Issue:12
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.
AID1127158Cytotoxicity against human HL60 cells after 48 hrs by WST-1 assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1127166Cytotoxicity against human HL60 cells assessed as decrease in cell viability at 50 ug/mL after 24 hrs by trypan blue assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID93707Inhibitory concentration of compound against strand transfer of HIV-1 integrase in experiment 21997Journal of medicinal chemistry, Mar-14, Volume: 40, Issue:6
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
AID1355865Inhibition of p115 DHPH22 domain (395 to 766 residues) (unknown origin) interaction with GDP-loaded His-tagged RhoA F25N mutant (1 to 180 residues) assessed as reduction in BODIPY-GTP-GDP exchange pretreated for 30 mins followed by RhoA addition by fluore2018Journal of natural products, 07-27, Volume: 81, Issue:7
Natural Inhibitors of the RhoA-p115 Complex from the Bark of Meiogyne baillonii.
AID1127159Cytotoxicity against human HeLa cells after 24 hrs by WST-1 assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID1755693Inhibition of Salmonella typhimurium LsrK expressed in Escherichia coli MET1158 incubated for 30 mins followed by DPD and ATP addition and measured after 15 mins by kinase-glo max luminescent assay2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Tackling Antimicrobial Resistance with Small Molecules Targeting LsrK: Challenges and Opportunities.
AID1127165Cytotoxicity against human HL60 cells assessed as metabolic activity at 50 ug/mL after 24 hrs by WST-1 assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Cytotoxic constituents from Lobaria scrobiculata and a comparison of two bioassays for their evaluation.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1799757Fluorescence Polarization (FP) Assay from Article 10.1016/j.chembiol.2012.05.013: \\Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.\\2012Chemistry & biology, Jul-27, Volume: 19, Issue:7
Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening.
AID1801643FabZ Inhibition Assay from Article 10.1021/acs.biochem.5b00832: \\u00DF-Hydroxyacyl-acyl Carrier Protein Dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: Structure Determination, Enzymatic Characterization, and Cross-Inhibition Studies.\\2016Biochemistry, Feb-23, Volume: 55, Issue:7
β-Hydroxyacyl-acyl Carrier Protein Dehydratase (FabZ) from Francisella tularensis and Yersinia pestis: Structure Determination, Enzymatic Characterization, and Cross-Inhibition Studies.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (3.85)18.2507
2000's2 (7.69)29.6817
2010's17 (65.38)24.3611
2020's6 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.68 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]